4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(5-methylpyridin-2-yl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Chemical Structure Depiction of
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(5-methylpyridin-2-yl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(5-methylpyridin-2-yl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide
Compound characteristics
| Compound ID: | L309-1200 |
| Compound Name: | 4-[(5-cyclobutyl-1,2,4-oxadiazol-3-yl)methyl]-N-(5-methylpyridin-2-yl)-3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-sulfonamide |
| Molecular Weight: | 455.49 |
| Molecular Formula: | C21 H21 N5 O5 S |
| Smiles: | Cc1ccc(NS(c2ccc3c(c2)N(Cc2nc(C4CCC4)on2)C(CO3)=O)(=O)=O)nc1 |
| Stereo: | ACHIRAL |
| logP: | 2.4733 |
| logD: | 2.2659 |
| logSw: | -2.901 |
| Hydrogen bond acceptors count: | 11 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 107.613 |
| InChI Key: | SSBJKGKJDYICAF-UHFFFAOYSA-N |